Artificial stone‐associated silicosis in China: A prospective comparison with natural stone‐associated silicosis

BACKGROUND AND OBJECTIVE: We recently noted a dramatic increase in the number of patients with accelerated silicosis associated with exposure to artificial stone dust. Therefore, the natural history of artificial stone‐associated silicosis was compared with that of natural stone‐associated silicosis. METHODS: A total of 18 patients with artificial stone‐associated silicosis and 63 with natural stone‐associated silicosis were diagnosed sequentially in 2018 and followed up for a period of 6–12 months. Data were collected from clinical charts. RESULTS: The median duration of exposure prior to onset of symptoms of silicosis was shorter for patients who had been exposed to artificial stone dust (6.4 vs 29.3 years, P < 0.01). Four of the 18 patients experienced rapid deterioration in lung function over the follow‐up period, with declines in pre‐bronchodilator FVC of 587 (210–960) mL/year and FEV(1) of 625 (360–860) mL/year. GGO, PMF, emphysema and pulmonary artery widening were more frequently observed on computed tomography scans of patients with artificial stone‐associated silicosis than of those with natural stone‐associated silicosis. Approximately 38.9% of the patients with artificial stone‐associated silicosis were lung transplant candidates and 27.8% died, both rates being significantly higher than in patients with natural stone‐associated silicosis (3.2% and 0%, both P < 0.01). CONCLUSION: Compared to natural stone‐associated silicosis, artificial stone‐associated silicosis was characterized by short latency, rapid radiological progression, accelerated decline in lung function and high mortality.